ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Viriom, Chromis’ Avifavir reduces time to virus elimination in Covid-19 patients
March 10, 2021Viriom and Chromis have reported that data from a study of directly acting antiviral drug, Avifavir (favipiravir) demonstrated reduced time to virus elimination in Covid-19 patients. -
Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for COVID-19
April 13, 2020Viriom announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus).
Pharma Sources Insight January 2025
